Publication | Closed Access

A Randomized, Double-Masked, Placebo-Controlled Study of Alicaforsen, an Antisense Inhibitor of Intercellular Adhesion Molecule 1, for the Treatment of Subjects With Active Crohn’s Disease

InflammationAnti-inflammatoryAntisense InhibitorMucosal ImmunologyGastrointestinal PharmacologyMedicineImmunologyGastroenterologyPlacebo-controlled StudyActive Crohn ’Pharmacology